Soluble ST2 Levels in End-Stage Heart Failure and During LVAD Support

Journal of Heart and Lung Transplantation - Netherlands
doi 10.1016/j.healun.2016.01.035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Risk Scores in End Stage Heart Failure

Cardiologia Croatica
Cardiovascular MedicineCardiology
2014English

IL-33/ST2 Pathway and Classical Cytokines in End-Stage Heart Failure Patients Submitted to Left Ventricular Assist Device Support: A Paradoxic Role for Inflammatory Mediators?

Mediators of Inflammation
ImmunologyCell Biology
2013English

Increased Levels of Plasma Soluble Sema4D in Patients With Heart Failure

PLoS ONE
Multidisciplinary
2013English

Soluble Receptor for Advanced Glycation End-Products Levels in Chronic Heart Failure and Its Correlation to Left Ventricular Ejection Function

Journal of Clinical & Experimental Cardiology
2013English

Altered Sarcoplasmic Reticulum Ca2(+)-ATPase Gene Expression in the Human Ventricle During End-Stage Heart Failure.

Journal of Clinical Investigation
Medicine
1990English

ST2 in Patients With Severe Aortic Stenosis and Heart Failure

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2013English

Soluble ST2 and Brain Natriuretic Peptide Predict Different Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction

Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Open Chest Epicardial Voltage Mapping During Left Ventricular Assist Device Implant in Patients With End-Stage Heart Failure

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Role of Cardiac Resynchronization in End-Stage Heart Failure Patients Requiring Inotrope Therapy

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy